STAT3 and osteosarcoma: established the folic acid-modified liposome QUE, which can inhibit the expression of PD-L1 in osteosarcoma by inhibiting JAK2/STAT3 signaling, antagonizing the proliferation and immune escape of osteosarcoma cells (152).